Megan Grossman
Physician Assistant · Camarillo, CANPI 1376027235
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 95.7% of the total across 99 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 39 manufacturers, the largest accounting for just 13.0% — the pattern of someone who eats at a lot of different presentations.
Across 99 payments — averaging $24.99 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lilly USA, LLC$322
- Incyte Corporation$320
- Novartis$204
- EMD Serono, Inc.$120
- Bristol Myers Squibb$84
- Ipsen Biopharmaceuticals, Inc$78
- plus $1K from 33 others
What the payments were for
- Food & beverage$2,36796%
- Education$1074%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
How this compares
$2,474 in reported general payments places this provider in the 85th percentile of 10,423 physician assistant providers in California.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| XtandiEnzalutamide | 19 | $241,859 |
| ImbruvicaIbrutinib | 11 | $171,116 |
| Abiraterone Acetate | 47 | $124,384 |
| OrgovyxRelugolix | 22 | $58,938 |
| EliquisApixaban | 38 | $23,579 |
| XareltoRivaroxaban | 11 | $10,454 |
| Anastrozole | 15 | $231 |
| Letrozole | 13 | $150 |
| Alendronate Sodium | 17 | $74 |
| Prednisone | 20 | $45 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Sumitomo Pharma America, Inc.Orgovyx | $44 | $58,93822 claims |
| PfizerEliquis | $74 | $23,57938 claims |
| Johnson & JohnsonXarelto | $39 | $10,45411 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 10,423 physician assistant providers in California.
Other physician assistant in Camarillo
- David DavisCamarillo$49K
- Andrea NguyenIrvine$1M
- Mikhail AlperMadera$889K
- Erin JensenUpland$716K
- Franklin ClineSacramento$458K
- Carla CrespoMarina del Rey$297K
- Katherine OsakiEl Centro$274K
- Shawna JonesFountain Valley$266K
- Heather AustinSalinas$219K
- Andrea FoxStanford$172K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.